Ambu A/S (OTCMKTS:AMBBY) Sees Unusually-High Trading Volume – Time to Buy?

Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY) saw unusually-strong trading volume on Thursday. Approximately 1,000 shares changed hands during mid-day trading, an increase of 55% from the average daily volume of 644 shares. The stock last traded at $13.60 and had previously closed at $12.10.

Analyst Ratings Changes

Separately, UBS Group downgraded Ambu A/S from a “strong-buy” rating to a “hold” rating in a report on Tuesday, September 15th. One research analyst has rated the stock with a Hold rating. Based on data from MarketBeat, the company currently has a consensus rating of “Hold”.

Ambu A/S Stock Performance

The firm has a 50 day moving average of $11.04 and a two-hundred day moving average of $10.99. The stock has a market cap of $3.20 billion, a PE ratio of 45.33 and a beta of 0.86. The company has a debt-to-equity ratio of 0.08, a current ratio of 2.77 and a quick ratio of 1.69.

Ambu A/S (OTCMKTS:AMBBY) last announced its earnings results on Thursday, November 5th. The company reported $0.14 EPS for the quarter. Ambu A/S had a net margin of 8.18% and a return on equity of 8.49%.

About Ambu A/S

Ambu A/S is a Danish medical technology company that develops, manufactures and markets single-use devices for hospitals and other healthcare providers. Its products are designed to support clinical procedures while reducing the need for cleaning, disinfection and reprocessing associated with reusable equipment.

The company’s portfolio includes single-use endoscopy systems, such as the aScope range of flexible endoscopes and related visualization equipment, as well as products for anesthesia, airway management, ventilation, resuscitation and patient monitoring.